Literature DB >> 11016619

Identification by cDNA microarray of genes involved in ovarian carcinogenesis.

K Ono1, T Tanaka, T Tsunoda, O Kitahara, C Kihara, A Okamoto, K Ochiai, T Takagi, Y Nakamura.   

Abstract

To identify genes involved in the development or progression of ovarian cancer, we analyzed gene expression profiles of nine ovarian tumors using a DNA microarray consisting of 9121 genes. Comparison of expression patterns between carcinomas and the corresponding normal ovarian tissues enabled us to identify 55 genes that were commonly up-regulated and 48 genes that were down-regulated in the cancer specimens. When the five serous adenocarcinomas were analyzed separately from the four mucinous adenocarcinomas, we identified 115 genes that were expressed differently between the two types of tumor. Investigation of these genes should help to disclose the molecular mechanism(s) of ovarian carcinogenesis and define molecular separation of the two most common histological types of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016619

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Identification of disease-specific genes in chronic pancreatitis using DNA array technology.

Authors:  H Friess; J Ding; J Kleeff; Q Liao; P O Berberat; J Hammer; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

2.  mRNA expression profiling of laser microbeam microdissected cells from slender embryonic structures.

Authors:  Stefan J Scheidl; Sven Nilsson; Mattias Kalén; Mats Hellström; Minoru Takemoto; Joakim Håkansson; Per Lindahl
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 3.  Molecular genetics of ovarian cancer.

Authors:  A N Shelling; W Foulkes
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

4.  Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.

Authors:  Ping Zhan; Xiao-Kun Shen; Qian Qian; Ji-Ping Zhu; Yu Zhang; Hai-Yan Xie; Chuen-Hua Xu; Ke-Ke Hao; Wei Hu; Ning Xia; Guo-Jun Lu; Li-Ke Yu
Journal:  Med Oncol       Date:  2011-04-26       Impact factor: 3.064

5.  Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip.

Authors:  Shen-Hua Xu; Li-Juan Qian; Han-Zhou Mou; Chi-Hong Zhu; Xing-Ming Zhou; Xiang-Lin Liu; Yong Chen; Wen-Yu Bao
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

6.  Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.

Authors:  Akira Tsuchiya; Michiie Sakamoto; Jun Yasuda; Makoto Chuma; Tsutomu Ohta; Misao Ohki; Toshiharu Yasugi; Yuji Taketani; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

7.  Integrin gene expression profiles of human hepatocellular carcinoma.

Authors:  Lian-Xin Liu; Hong-Chi Jiang; Zhi-Hua Liu; Jing Zhou; Wei-Hui Zhang; An-Long Zhu; Xiu-Qin Wang; Min Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 8.  Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review.

Authors:  Manfred Dietel; Christine Sers
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

Review 9.  Molecular signatures of ovarian cancer: from detection to prognosis.

Authors:  Christine S Walsh; Beth Y Karlan
Journal:  Mol Diagn Ther       Date:  2010-02-01       Impact factor: 4.074

10.  Expression profiles of two types of human knee-joint cartilage.

Authors:  Kensuke Ochi; Yataro Daigo; Toyomasa Katagiri; Akihiko Saito-Hisaminato; Tatsuhiko Tsunoda; Yoshiaki Toyama; Hideo Matsumoto; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-02-21       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.